Heterodimeric structure of the spider toxin ω-Agatoxin IA revealed by precursor analysis and mass spectrometry by Olivera, Baldomero M. & Santos, Ameurfina D.
 at UNIV O










THE JOURNAL OF BIOLOGICAL CHEMISTRY 
© 1992 by The American Society for Biochemistry and Molecular Biology, Inc. 
Vol. 267, No. 29, Issue of October 15, pp. 20701-20705, 1992 
Printed in U.S.A. 
Heterodimeric Structure of the Spider Toxin w-Agatoxin IA Revealed 
by Precursor Analysis and Mass Spectrometry* 
(Received for publication, April 10, 1992) 
Ameurfina D. Santos:j:§~, Julita s. Imperial:j:, Tanuja Chaudhary II , Ronald C. Beavis II , 
Brian T. Chait II , John P. Hunsperger:j:, BaldomeroM. Olivera:j:, Michael E. Adams··, and 
David R. Hillyard:j: :j::j: 
From the +Departments of Biology and Pathology, University of Utah, Salt Lake City, Utah 84112, the §Institute of Chemistry, 
University of the Philippines, Diliman, Quezon City 1101, Philippines, IIRockefeller University, New York, New York 10021, and 
the ** Departments of Entomology and Neuroscience, University of California, Riverside, California 92521 
We report the first molecular characterization of a 
precursor sequence for a small, Ca2 + channel blocking, 
peptide spider toxin, w-agatoxin IA. By integrating 
information generated from a molecular genetic ap-
proach using agatoxin cDNAs with data provided from 
mass spectrometry of the mature toxin, we were able 
to deduce the likely mechanisms by which the toxin 
precursor peptide is processed to its mature heterodi-
meric form. A particularly interesting feature of the 
prepropeptide is the occurrence of two glutamate-rich 
sequences interposed between the signal sequences, the 
major peptide toxin, and the minor toxin peptide. Ex-
cision of the more distal glutamate-rich region appears 
to be signaled by flanking arginine residues but likely 
occurs only after a disulfide linkage has formed be-
tween the major and minor chains of the mature toxin. 
Our molecular genetic approach toward characterizing 
this toxin will allow us to quickly generate a series of 
spider sequences from which mature toxin structures 
can be deduced and eventually expressed. Additionally, 
this approach will provide insights into the evolution-
ary divergence observed among spider peptide toxins. 
Spiders contain a diverse array of toxic compounds in their 
venoms. There are at least three distinctive chemical classes 
that have been chemically characterized. First are the organic 
polyamine compounds, such as the a-agatoxins and argiotox-
ins; these have been shown to block glutamate receptor chan-
nels. Second are large proteins such as a-Iatrotoxin from 
black widow spider venom (molecular mass = 120 kDa) (Ki-
yatkin et at., 1990). Perhaps the largest and most diverse 
group of spider toxins are the small, disulfide-rich polypep-
tides, typically 40-90 amino acids in length. Such small poly-
peptide toxins have been described in a variety of spiders 
including Atrax robustus (Sheumack et at., 1985; Brown et at., 
1988), Hototena curta (Stapleton et at., 1990; Quistad et at., 
1991), Ptectruerys tristis (Branton et at., 1987), and Ageten-
opsis aperta. 
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In the funnel web spider, Agelenopsis aperta, a large variety 
of small polypeptide toxins are present. Two general classes 
have been identified, the wagatoxins (Skinner et at., 1989), 
which activate Na2+ channels at the insect neuromuscular 
junction (Adams et at., 1989), and the w-agatoxins. The w-
agatoxins specifically inhibit voltage-sensitive Ca2+ channels 
(Adams et at., 1990; Scott et at., 1990; Mintz et at., 1991, 1992; 
Venema et at., 1992). Four different classes of w-agatoxins 
have been described, each with divergent biochemical char-
acteristics and pharmacological specificity (Olivera et at., 
1991; Adams et at., 1992). The first of these to be character-
ized, w-Aga-IA,t is a potent antagonist of presynaptic Ca2+ 
channels at insect neuromuscular junctions (Bindokas and 
Adams, 1989; Adams et at., 1990; Bindokas et at., 1991). 
The primary structure of w-Aga-IA was reported to be an 
unblocked, 66-amino acid peptide (Adams et at., 1990; see Fig. 
1). Unlike virtually every peptide toxin described previously, 
w-Aga-IA appeared to contain 9 cysteine residues. Since cys-
teine residues typically are involved in disulfide bonding, the 
presence of an odd number suggested that one of these resi-
dues might be present in a reduced form. However, alkylation 
experiments carried out to detect free sulfhydryl moieties 
were consistently negative. Furthermore, mass spectrometry 
studies indicated the association of an undefined moiety that 
is removed upon exposure of the peptide to reducing condi-
tions (Chaudhary et al., 1991). 
We report here both the precursor structure of w-Aga-IA 
and a modified structure for the mature toxin. By using a 
cDNA cloning approach, an w-Aga-IA clone was identified 
from an A. aperta cDNA library and sequenced. This is the 
first small polypeptide toxin precursor from spiders to be 
reported. The structure of the toxin precursor, supported by 
mass spectroscopy and sequencing data, revealed that the 
mature w-agatoxin IA consists of two polypeptide chains, 
which are formed from the precursor by excision of an internal 
heptapeptide. 
EXPERIMENTAL PROCEDURES 
Materials-Oligonucleotide probes and primers were synthesized 
on an Applied Biosystems 380B synthesizer. Nitrocellulose blotting 
membranes and ['Y_32P]ATP were purchased from Amersham. The 
FastTrack mRNA isolation kit was purchased from Invitrogen. Se-
quencing reactions were performed with Sequenase Version 2 from 
United States Biochemical. 
RNA Preparation-Venom ducts hand-dissected from 200 adult A. 
aperta spiders were frozen in liquid nitrogen, ground to powder, and 
extracted in an SDS/proteinase K solution (FastTrack mRNA iso-
I The abbreviations used are: w-Aga-IA, w-agatoxin IA; SDS, so-
dium dodecyl sulfate; HPLC, high-performance liquid chromatogra-
phy; kb, kilobase(s). 
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20702 Heterodimeric Structure of w-Aga-IA 
AKALPPGSVCDGNEgDCKCY~KWHKCRCPWKW ... 
HFTGEGPCTCEKGMKHTCITKLHCPNKAEWGLDW 
FIG. 1. The previously determined amino acid sequence of 
w-agatoxin IA. It is demonstrated in this article that this sequence 
represents only one of two polypeptide chains in the mature toxin. 
The sequences corresponding to the oligonucleotide probes used to 
identify w-Aga-IA cDNA clones are boxed. 
lation kit from Invitrogen). Poly(A)+ RNA was subsequently batch-
annealed to oligo(dT) cellulose, washed, and eluted from a spin 
column. 
Vector-The polylinker region of plasmid pGEM 3Zf+ was ex-
tended to include five additional sites by cloning into the EcoRI and 
Kpnl sites a synthetic oligomer sequentially encoding EcoRI, Sac!, 
EcoRV, Notl, Sphl, Nsil, Stul, BglII, and KpnI. The extension was 
created in order to flank cDNA inserts on each side with six to eight 
restriction sites, thereby facilitating subsequent manipulations with 
any useful clone. The modified plasmid is designated pDH52. 
Vector-primer Preparation-Cesium gradient-purified plasmid 
pDH52 was passed over a Bio-Gel A150m column, cleaved with KpnI, 
and T -tailed with terminal transferase to a mean length of 72 ± 8 
bases. Following a second cleavage with BamHI and removal of the 
free T -tail by agarose gel electrophoresis, a vector-primer was gener-
ated which allows cDNA inserts to be unidirectionally and coordi-
nately oriented with respect to lacZa. 
cDNA Library Construction-First strand cDNA synthesis was 
initiated with 5 mg of methylmercury-denatured poly(A)+ RNA an-
nealed to 1 pmol of vector-primer in the presence of AMV reverse 
transcriptase. Second strand synthesis was performed essentially 
according to the RNase H/Pol I protocol of Okayama and Berg 
(1982), and the product was blunt-ended with T4 polymerase. Follow-
ing protection of all EcoRI sites with EcoRI methylase, the blunt 
termini of the vector-cDNA were ligated to EcoRI linkers 
d(pCGGAATTCCG) which earlier had been partially ligated to the 
5-mer level. Cohesive ends were then generated with EcoRI, and the 
product was electrophoresed in low melting temperature agarose. Six 
discrete size fractions of cDNA were recovered by CTAB purification 
(Langridge et at., 1980). The recovered fractions of vector-cDNA 
molecules were individually recircularized, ligated, and electroporated 
into MCI061 (F' lac Iq, Tn5) yielding a multiply size-fractionated 
library composed of 3.0 X 106 independent clones. 
Synthesis of Oligonucleotides-All oligonucleotides used as probes 
for screening the cDNA library and primers for sequencing were 
synthesized using the Applied Biosystems 380B synthesizer. One 
probe was used for screening; four primers for sequencing. 
Library Screening-Samples from appropriate cDNA size fractions 
were replica-plated onto nitrocellulose membranes and prepared for 
colony hybridization (Hanahan and Meselson, 1980). The nucleotide 
sequences of mixed 17 -mer probes were inferred from amino acid 
sequence information determined from purified toxin preparations. 
Probes were 5'-end-labeled with [-y-32PJATP and T4 polynucleotide 
kinase. To identify individual clones containing the w-Aga-IA peptide 
sequence, probe 190 was used. Probe 190 is a 32-mix 17-mer oligo-
nucleotide 5'CCRTARCAYTTRCARTC3' (R = A or G, Y = C or T) 
which is complementary to the cDNA sequence corresponding to six 
amino acids of the w-Aga-IA peptide. About 3500 colonies were plated 
out from each of three size fractions of the cDNA library, and 
duplicate nitrocellulose filter lifts were prehybridized in 3 M tetra-
methylammonium chloride, 0.1 M phosphate buffer, pH 6.8, 1 mM 
EDTA,5 x Denhardt's, 0.6% SDS, and 100 Itg/ml denatured salmon 
sperm DNA at 48 °c for 3 h. The filters were then hybridized for 40 
hat 48 °c in the same solutions with the addition of 16 pmol of probe 
190 which were 5' -end-labeled with [-y-32PJATP by T4 polynucleotide 
kinase. The filters were washed 4 times: 2 x with 3 M tetramethyl-
ammonium chloride, 50 mM Tris, 0.2% SDS, first for 15 min at room 
temperature followed by 1 h at 50 °C; and twice more with 2 x SSC, 
0.1 % SDS, both at room temperature. The filters were then exposed 
to x-ray film using intensifying screens at -70°C for 24 h. Well-
isolated positive clones on both duplicate filters were picked. 
Sequencing-Five Itg of cesium gradient-purified plasmid was de-
natured in 0.4 M NaOH for 0.5 h at 37 °C and neutralized by adjusting 
to 0.4 M ammonium acetate. The DNA was ethanol-precipitated, 
resuspended in 8 ml of H20, and annealed with 2 pmol of sequencing 
primer by heating to 65 °C for 5 min and cooling slowly to 30 °C. 
Labeling and termination reactions were performed as specified by 
the protocol accompanying the Sequenase Version 2.0 enzyme. 
Dideoxy sequencing was performed on alkali -denatured supercoiled 
plasmid DNA purified by centrifugation to equilibrium in CsCl-
ethidium bromide gradients. A Sequenase Version 2.0 sequencing kit 
of United States Biochemical was used following the manufacturer's 
protocol. 
Peptide Isolation and Characterization-w-Aga-IA was HPLC-pu-
rified from whole A. aperta venom (purchased from Spider Pharm, 
Black Canyon City, AZ) as previously described (Adams et at., 1990). 
Native peptide was concentrated to dryness using a Speed-Vac (Sa-
vant Instruments) and submitted to the University of California 
Riverside Biotechnology Instrumentation Facility for Edman se-
quence analysis. Sequencing was carried out using an Applied Bio-
systems, Inc. instrumentation which included a Model 475-A liquid-
pulsed sequenator, on-line phenylthiohydantoin analysis on the 120A 
HPLC, and data collection and reduction with a Model 900-A com-
puter and Applied Biosystems' version 2.42 software. Applied Biosys-
terns' phenylthiohydantoin standards, chemicals, and reagents were 
used throughout. All sequence calls were confirmed by visual exami-
nation of the chromatograms. 
Mass Spectrometry-Mass spectrometric measurements were per-
formed on the 252Cf plasma desorption and matrix-assisted laser 
desorption time-of-flight mass spectrometers constructed at the 
Rockefeller University and described previously (Chait et al., 1981; 
Chait and Field, 1984; Beavis and Chait, 1990a, 1990b). Samples were 
prepared for measurement by 252Cf plasma desorption mass spectrom-
etry by absorption of approximately 1 nmol of toxin in 0.1 % trifluo-
roacetic acid to a thin layer of nitrocellulose as described previously 
(Chait and Field, 1986). Samples were prepared for matrix-assisted 
laser desorption mass spectrometry by applying 1 pmol of the toxin 
in a saturated solution of 3-methoxy-4-hydroxycinnamic acid (in 30% 
acetonitrile, 0.1% trifluoroacetic acid) to a metal probe tip, drying 
the solution with a stream of cool air, and inserting the probe into 
the mass spectrometer (Beavis and Chait, 1989). The mass accuracies 
of both techniques were approximately 100 ppm. 
RESULTS 
Construction of A. aperta Library; Identification of w-Aga-
IA cDNA Clones-A cDNA library (3.0 X 106 independent 
clones) was prepared from A. aperta venom duct poly(A)+ 
RNA as described under "Experimental Procedures." The 
library was size-fractionated into six size classes. 
A mixed 17-mer oligonucleotide probe specific for w-Aga-
IA was labeled and used to probe the 0.40-0.45- and 0.45-
0.55-kb size fractions of the cDNA library. Approximately 4% 
of all cDNA clones in these size fractions hybridized to the 
probe; eight independent clones were analyzed further by a 
partial sequence analysis. Six of these appeared to have iden-
tical sequences; the other two encoded a minor variant pre-
cursor form of w-Aga-IA (which will be described elsewhere).2 
Three of the six major variant clones of w-Aga-IA were 
completely sequenced; all encoded the same open reading 
frame. 
Sequence of the w-Aga-IA Precursor-The w-Aga-IA cDNA 
clones encoded a 112 amino acid polypeptide; both the nu-
cleotide sequence and deduced amino acid sequence are shown 
in Fig. 2. Fig. 2 shows a schematic analysis of the different 
regions in the polypeptide precursor for w-Aga-IA. The under-
lined region in Fig. 2 corresponds to the amino acid sequence 
obtained when purified w-Aga-IA was initially biochemically 
characterized. Clearly, however, the predicted precursor se-
quence of w-Aga-IA includes three other distinctive regions. 
The N terminus encodes a typical signal sequence (bracketed). 
This is followed by a short hydrophilic region, highly enriched 
in glutamate residues. At the C-terminal end are 10 additional 
amino acids which were not detected after the original toxin 
had been reduced and alkylated and the purified product had 
been sequenced (Adams et al., 1990). The most noteworthy 
features of the C-terminal extension are that it contains a 
small glutamate-rich region flanked by 2 arginine residues 
and a C-terminaI cysteine residue. Thus, together with the 
2 A. D. Santos and D. R. Hillyard, unpublished observation. 
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66-amino acid polypeptide that was sequenced after toxin 
purification, the C-terminal fragment would yield a 76-amino 
acid precursor with 10 Cys residues; these could presumably 
form five disulfide bonds. 
However, the previous Edman sequencing results (Adams 
et at., 1990) indicated that a proteolytic event must have 
occurred following Trp-66, since this residue was found at the 
C-terminal end of the reduced and carboxymethylated toxin. 
If the Cys residue on the C-terminal decapeptide (or some 
fragment derived from it) were linked by a disulfide bond to 
the main chain, such a disulfide-bonded peptide fragment 
would have been lost during the reduction and carboxymeth-
ylation procedures. In order to investigate this possibility, 
both the native and reduced toxin were analyzed by mass 
spectrometry. In addition, Edman sequencing was carried out 
on the native toxin. 
Mass Spectrometry of w-Aga-IA-Native w-Aga-IA, purified 
by reversed-phase HPLC was subjected to 252Cf plasma de-
sorption mass spectrometry. The spectrum (shown in Fig. 3) 
indicated a molecular mass (MM) of 7791.4 Da, which is 303.7 
Da higher than that predicted from the previously published 
(Adams et al., 1990) Edman sequencing data (7487.7 Da). A 
search for modification(s) of the peptide using plasma desorp-
tion mass spectrometry of the trypsin and cyanogen bromide 
cleavage products of w-Aga-IA showed no altered residues and 
confirmed the Edman sequencing data. However, since all of 
the enzymatic and chemical procedures used previously were 
preceded by a reduction step to open up the tightly cross-
linked polypeptide, we hypothesized that the reduction may 
have removed a 304.7-Da component present on the native 
material. The PD mass spectrum of dithiothreitol reduced w-
Aga-IA was, however, too weak to be informative. 
Further analysis with matrix-assisted UV laser desorption 
time-of-flight mass spectrometry confirmed the results ob-
tained with plasma desorption mass spectrometry, but gave 
much higher quality mass spectra (see Fig. 4). Thus, we were 
able to obtain an intense mass spectrum from dithiothreitol-
~-=~~~==~-=~-=======~ 
[met met lya phe val val ph. leu ala cya l,!u ph. val ala 14 
=~==~=~=~~~~-~=~=~~~~ 
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91u arq 0]' lye ale Jell pro pro e'Y Iftr val cva .. p e'Y "0 gll! Iftt "P cX' lyl 54 
reT TAT GGe AM TCG CAT AAG 'fCC CGC rGC eeA TGG AAG TGG CAe TTT ACT GGA eM GGA 240 
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FIG. 2. cDNA sequence of clones encoding the 112 amino 
acid w-Aga-IA precursor. Both the nucleotide and predicted amino 
acid sequence are indicated. The previously determined amino acid 
sequence is underlined. 
FIG. 3. 252Cf plasma desorption 
mass spectrum of native w-Aga-IA. 
The spectrum indicates a dominant spe-
cies with molecular mass (MM) of 7791.4 
Da, a value 303.7 Da higher than the 
mass of 7487.7 Da calculated from the 
sequence. 
9000 
reduced w-Aga -IA. The reduced material had a molecular mass 
of 7495.3 Da, matching the value predicted from the amino 
acid sequence of the major chain (7495.8 Da) and demonstrat-
ing the removal of a component with a mass of 304.7 Da. This 
mass value exactly matches the predicted mass of the C-
terminal tripeptide of the precursor, Ser-Pro-Cys. Thus, it 
appears that the sulfhydryl in the native peptide is not free. 
Loss of 303.7 Da following exposure of the peptide to reducing 
conditions is consistent with the hypothesis that the C-ter-
minal tripeptide of the precursor sequence (SPC) is linked to 
the major 66 amino acid chain by a disulfide bond, and that 
the heptapeptide sequence RSEESER was excised. 
Amino Acid Sequencing of Native w-Aga-IA-Previous pep-
tide sequence analyses of w-Aga-IA (Adams et at., 1990) were 
performed consistently on the reduced, alkylated peptide. 
Since the combined data from precursor cDNA sequencing 
and mass spectrometry indicate that this procedure may have 
resulted in loss of the presumed native dimeric character of 
the molecule, we subjected the native toxin to N-terminal 
sequence analysis without the intervention of reducing con-
ditions. Results of this analysis yielded the following amino 
acid assignments through the first 4 cycles of Edman sequenc-
ing: cycle 1, A+S; cycle 2, K+P; cycle 3, A; cycle 4, L (Table 
I). Higher molar ratios for A and K on the first two sequence 
cycles probably resulted from the presence of reducing re-
agents in the sequencing protocols, leading to a greater loss 
of the tripeptide during the intervening wash cycles. The lack 
of a Cys residue registered on the cycle 3 of the sequence was 
expected, since no reduction and alkylation was performed. 
These data are consistent with the presence of two N-
terminal sequences coming from a major chain (66 amino 
acids) and a minor chain (3 amino acids) processed from the 
precursor molecule. The combined data taken from cDNA 
sequencing, Edman sequencing, and mass spectrometry thus 
indicates that the mature biologically active w-Aga-IA is a 69-
amino acid heterodimer consisting of a major chain (66 amino 
acids) and a minor chain (3 amino acids), with an interchain 
disulfide linkage. 
DISCUSSION 
In this work we report the precursor structure for w-aga-
toxin lA, a small polypeptide spider toxin which blocks Ca2+ 
channels at the insect neuromuscular transmission as well as 
in mammalian sensory neurons (Bindokas and Adams, 1989; 
Bindokas et at., 1991; Scott et at., 1990). Our characterization 
of the w-Aga-IA precursor is based upon sequence analysis of 
cDNA clones isolated from an A. aperta venom duct cDNA 
library. In the course of determining the toxin precursor 
structure we were also able to deduce the structure of the 
mature, biologically active toxin. 
The organization of the precursor structure of w-agatoxin 
IA is consistent with a prepropeptide format. After processing, 
the mature toxin comprises two polypeptide chains, a larger 
fragment of 66 amino acids which is disulfide-bonded to a 
!M+2HJ2+ Measured MM = 7791.4 
Calculated MM = 7487.7 
!M+HJ+ 
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Measu=! MM = 7495.3 
calculated MM = 7495.8 (M+Hl + 
O~-r.-ro-r.-ro-r.-,,-.,-.-,,-..-,,-..-,,-.-r~ 
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FIG. 4. Matrix-assisted laser desorption mass spectrum of 
w-Aga-IA that has been subjected to reduction by dithiothre-
itol. The mass spectrum shows a dominant species with molecular 
mass (MM) of 7495.3 Da, resulting from the loss from the native 
toxin of an entity with mass 305 Da and the addition of 9 hydrogens 




N-terminal sequence analysis of native w-Aga-IA 
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Glu Rich Glu Rich Mature Toxin 
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FIG. 5. Diagrammatic representation of w-Aga-IA precur-
sor and the presumed processing steps to the mature toxin 
showing functional domains, including signal sequence (black 
bar), Glu-rich sequence (striped bar), major chain (shaded 
bar), excised domain (striped bar), and minor chain (shaded 
bar). In addition to the signal peptidase, at least one other proteolytic 
activity which cleaved at Arg residues bordering Glu-rich regions 
would be required. It is possible that other proteolytic activities (such 
as aminopeptidases) participate in processing. 
small tripeptide with sequence Ser-Pro-Cys. Our cDNA se-
quencing data, together with supporting biochemical evidence, 
indicate that the mature toxin is formed by proteolytic exci-
sion of both the N-terminal region ofthe w-Aga-IA precursor, 
as well as an internal peptide toward the C terminus. The 
processing of precursor to mature toxin requires at least two 
proteolytic enzymes, i.e. a signal peptidase, as well as a pro-
tease specific for arginine residues. A summary of the pre-
sumed processing steps is shown in Fig. 5. 
A novel feature of the predicted precursor of w-agatoxin IA 
is the presence of two short acidic regions, one between the 
signal sequence and the N terminus of the major chain, and 
the second between the major chain and the tripeptide at the 
C terminus. The presence of two glutamate-rich sequences in 
the w-Aga-IA precursor raises the obvious question of func-
tion. One possible explanation is that these regions serve as 
part of the recognition site for proteolytic cleavage, since the 
3 arginine residues all border glutamate-rich regions. It should 
be noted that such glutamate-rich regions have previously 
been described in other small peptide precursors (Richter et 
aI., 1990); in those cases as well, flanking arginine residues 
appear to be signals for proteolytic cleavage. Whether or not 
these glutamate-rich regions serve other functions is not 
known at the present time. Some other possibilities might be 
folding of the highly positively charged mature toxin, or to 
promote condensation of the toxin into secretory granules. 
Since w-Aga-IB, like w-Aga-IA, is known to contain 9 
cysteine residues (Adams et al., 1990) a processing pattern 
similar to that described for w-Aga-IA can be anticipated, 
leading to a dimeric mature toxin form. The first spider toxin 
to be described as a presynaptic antagonist of insect neuro-
muscular transmission, Hololena toxin (Bowers et al., 1987) 
also appears to be dimeric. However, all other spider toxins, 
the Type II, Type III, and Type IV w-agatoxins, the w 
agatoxins, as well as the Plectruerys toxins (Branton et al., 
1987) appear to be monomers. 
It is interesting to compare the precursor structure eluci-
dated here with those of the various other disulfide-rich 
polypeptide toxins. Apart from the internal peptide excision, 
the w-Aga-IA precursor exhibits some features that are inter-
mediate between the a-neurotoxins of snakes, and the smaller 
conotoxins from cone snail venom. While the mature region 
of snake toxin precursors immediately follows the signal 
sequence (see for example Tamiya et al., 1985), the corre-
sponding region in cone snails follows both a signal sequence 
and a long intervening region (Woodward et al., 1990; Colledge 
et al., 1992). In w-Aga-IA, the signal sequence precedes a 
relatively short intervening region, enriched with glutamate 
residues. An analysis of other spider toxin precursors has 
shown that the presence of a short glutamate-rich region 
between the signal sequence and the mature toxin may be a 
general characteristic of small polypeptide precursors from 
spider venom ducts.3 
Our molecular approach to analyzing spider toxins has 
considerable potential. Not only is there the possibility of 
elucidating precursor structure from toxins that have already 
been biochemically characterized, but the availability of 
clones should eventually permit efficient expression of the 
toxin. This approach can also solve problems associated with 
acquiring adequate quantities of minor constituent toxins, or 
of chromatographically separating closely related molecular 
species whose pharmacological properties can be very distinct. 
Furthermore, a molecular approach avoids the tedious tasks 
of milking spiders and purifying toxins from the venom. It 
also obviates the need to maintain large colonies of spiders 
since, in principle, only a few specimens will be required. By 
using a molecular approach to characterize and express spider 
toxins, these valuable ligands for receptors and ion channels 
can be made much more accessible to the scientific commu-
nity. Finally, a systematic molecular analysis of spider toxin 
genes will eventually provide a rich data base for insights into 
the molecular evolutionary mechanisms which helped to gen-
erate the great diversity of spider species. 
3 D. Hillyard, V. Monje, A. Santos, and M. Adams, unpublished 
results. 
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